{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:00:34Z","timestamp":1758056434258,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.7759\/cureus.92373","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:01:26Z","timestamp":1757948486000},"source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory Myofibroblastic Tumor of the Tongue: A Rare Case in a Pediatric Patient"],"prefix":"10.7759","author":[{"given":"Caterina","family":"Unia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"De Rosnay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vianney","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Sohier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Le Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihs\u00e8ne","family":"Taihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213393.57322.c7","article-title":"Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases","volume":"31","author":"Coffin CM","year":"2007","unstructured":"Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007, 31:509-20. 10.1097\/01.pas.0000213393.57322.c7","journal-title":"Am J Surg Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2019.03.004","article-title":"Clinical characteristics, histopathology, and treatment outcomes in adult and pediatric patients with nonspecific orbital inflammation","volume":"31","author":"Eshraghi B","year":"2019","unstructured":"Eshraghi B, Sonbolestan SA, Abtahi MA, Mirmohammadsadeghi A. Clinical characteristics, histopathology, and treatment outcomes in adult and pediatric patients with nonspecific orbital inflammation. J Curr Ophthalmol. 2019, 31:327-34. 10.1016\/j.joco.2019.03.004","journal-title":"J Curr Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.advms.2022.02.002","article-title":"What do we know about inflammatory myofibroblastic tumors? - a systematic review","volume":"67","author":"Siemion K","year":"2022","unstructured":"Siemion K, Reszec-Gielazyn J, Kisluk J, Roszkowiak L, Zak J, Korzynska A. What do we know about inflammatory myofibroblastic tumors? - a systematic review. Adv Med Sci. 2022, 67:129-38. 10.1016\/j.advms.2022.02.002","journal-title":"Adv Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-58710-9","article-title":"Soft Tissue Tumors: A Practical and Comprehensive Guide to Sarcomas and Benign Neoplasms","author":"Mocellin S","year":"2021","unstructured":"Mocellin S. Soft Tissue Tumors: A Practical and Comprehensive Guide to Sarcomas and Benign Neoplasms. Springer, Cham, Switzerland; 2021. 10.1007\/978-3-030-58710-9"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.049387","article-title":"Inflammatory myofibroblastic tumours: where are we now?","volume":"61","author":"Gleason BC","year":"2008","unstructured":"Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now?. J Clin Pathol. 2008, 61:428-37. 10.1136\/jcp.2007.049387","journal-title":"J Clin Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.11.023","article-title":"Oral inflammatory myofibroblastic tumor demonstrating ALK, p53, MDM2, CDK4, pRb, and Ki-67 immunoreactivity in an elderly patient","volume":"99","author":"Brooks JK","year":"2005","unstructured":"Brooks JK, Nikitakis NG, Frankel BF, Papadimitriou JC, Sauk JJ. Oral inflammatory myofibroblastic tumor demonstrating ALK, p53, MDM2, CDK4, pRb, and Ki-67 immunoreactivity in an elderly patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005, 99:716-26. 10.1016\/j.tripleo.2004.11.023","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref7","article-title":"Imagerie Rhumatologique et Orthop\u00e9dique Tome 4: Tumeurs et Pseudo-tumeurs Osseuses","author":"Laredo J","year":"2015","unstructured":"Laredo J, Wybier M, Petrover D, Morvan G. Imagerie Rhumatologique et Orthop\u00e9dique Tome 4: Tumeurs et Pseudo-tumeurs Osseuses. Sauramps M\u00e9dical, Montpellier, France; 2015."},{"key":"ref8","article-title":"Pathology and Genetics of Tumours of Soft Tissue and Bone","author":"Fletcher CDM","year":"2002","unstructured":"Fletcher CDM, Unni KK, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. International Agency for Research on Cancer, Lyon, France; 2002."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.10008","article-title":"Tumeur myofibroblastique inflammatoire de la vessie","volume":"5","author":"Jomaa W","year":"2011","unstructured":"Jomaa W, Ziadi S, Trimeche M, Hammedi F, Ben Sorba N, Mokni M, Korbi S. Tumeur myofibroblastique inflammatoire de la vessie. Can Urol Assoc J. 2011, 5:E4-6. 10.5489\/cuaj.10008","journal-title":"Can Urol Assoc J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1309\/r2q9ccuvtlrycf3h","article-title":"Anaplastic large cell lymphoma","volume":"127","author":"Medeiros LJ","year":"2007","unstructured":"Medeiros LJ, Elenitoba-Johnson KS. Anaplastic large cell lymphoma. Am J Clin Pathol. 2007, 127:707-22. 10.1309\/r2q9ccuvtlrycf3h","journal-title":"Am J Clin Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence B","year":"2000","unstructured":"Lawrence B, Perez-Atayde A, Hibbard MK, et al.. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000, 157:377-84. 10.1016\/S0002-9440(10)64550-6","journal-title":"Am J Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.10267","article-title":"ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor","volume":"38","author":"Debiec-Rychter M","year":"2003","unstructured":"Debiec-Rychter M, Marynen P, Hagemeijer A, Pauwels P. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer. 2003, 38:187-90. 10.1002\/gcc.10267","journal-title":"Genes Chromosomes Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.lab.0000088856.49388.ea","article-title":"Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor","volume":"83","author":"Debelenko LV","year":"2003","unstructured":"Debelenko LV, Arthur DC, Pack SD, Helman LJ, Schrump DS, Tsokos M. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest. 2003, 83:1255-65. 10.1097\/01.lab.0000088856.49388.ea","journal-title":"Lab Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/147323000903700332","article-title":"Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours","volume":"37","author":"Jiang YH","year":"2009","unstructured":"Jiang YH, Cheng B, Ge MH, Cheng Y, Zhang G. Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours. J Int Med Res. 2009, 37:867-77. 10.1177\/147323000903700332","journal-title":"J Int Med Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20294","article-title":"Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis","volume":"45","author":"Chun YS","year":"2005","unstructured":"Chun YS, Wang L, Nascimento AG, Moir CR, Rodeberg DA. Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis. Pediatr Blood Cancer. 2005, 45:796-801. 10.1002\/pbc.20294","journal-title":"Pediatr Blood Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1684\/bdc.2011.1311","article-title":"[Guidelines for management of localized inflammatory myofibroblastic tumours in children]","volume":"98","author":"Marie-Cardine A","year":"2011","unstructured":"Marie-Cardine A, Berrebi D, Orbach D. [Guidelines for management of localized inflammatory myofibroblastic tumours in children]. Bull Cancer. 2011, 98:209-16. 10.1684\/bdc.2011.1311","journal-title":"Bull Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2006.01.005","article-title":"Inflammatory myofibroblastic tumour of the tongue: a case report","volume":"45","author":"Gleizal A","year":"2007","unstructured":"Gleizal A, Ranchere-Vince C, Beziat JL. Inflammatory myofibroblastic tumour of the tongue: a case report. Br J Oral Maxillofac Surg. 2007, 45:423-4. 10.1016\/j.bjoms.2006.01.005","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.5070\/D31Q0631BM","article-title":"Inflammatory myofibroblastic tumor of the tongue: report of an unusual case in a teenage patient","volume":"18","author":"Louren\u00e7o SV","year":"2012","unstructured":"Louren\u00e7o SV, Boggio P, Simonsen Nico MM. Inflammatory myofibroblastic tumor of the tongue: report of an unusual case in a teenage patient. Dermatol Online J. 2012, 18:6.","journal-title":"Dermatol Online J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30116-4","article-title":"Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial","volume":"6","author":"Sch\u00f6ffski P","year":"2018","unstructured":"Sch\u00f6ffski P, Sufliarsky J, Gelderblom H, et al.. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial. Lancet Respir Med. 2018, 6:431-41. 10.1016\/S2213-2600(18)30116-4","journal-title":"Lancet Respir Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395668-inflammatory-myofibroblastic-tumor-of-the-tongue-a-rare-case-in-a-pediatric-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:01:27Z","timestamp":1757948487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395668-inflammatory-myofibroblastic-tumor-of-the-tongue-a-rare-case-in-a-pediatric-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.92373","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}